Frontiers in Psychiatry, 9, 44
She also frequently writes about food trends for various publications including Today's Dietitian Magazine , where she is a Trend Watch columnist
September 5th, 2025: Research Suggests GLP-1 Medications May Raise Kidney Cancer Risk Amid Growing Litigation A new study published in JAMA Oncology suggests that GLP-1 receptor agonists such as Ozempic and Mounjaro could increase the risk of kidney cancer, despite appearing to lower the risk of certain other cancers
In their article, the researchers detail how these medications can both directly and indirectly reduce liver fat, inflammation, and fibrosis, potentially improving disease outcomes
First, a quick primer on the three hormones To really answer the question how does Retatrutide work , it helps to look at the three different hormones it acts on
2025;26(8):e13929